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been estimated at 14% (95% CI: 7-22%). Risk factors for MTCT of 
HIV are advanced HIV disease and maternal immune deficieny, high 
maternal HIV viral load, maternal vitamin A deficiency, IV drug use 
and obstetrical instrumentation. Potential interventions aimed at re- 
ducing MTCT of HIV include: use of antiremvkk, vaginal disin- 
fection, vitamin A supplementanon, passive and/or active immuno- 
prophylaxis, breastfeeding alternatives, and treatment of STDs during 
pregnancy. Recently, Zidovudine (ZDV) given to pregnant women 
during gestation and delivery and to their newborns has been shown 
to reduce MTCT by two thirds. This regunen is now hrgely offered 
to HIV-infected pregnant women identified in indusaialised coun- 
tries. However it applicability in developing countries re& highly 
problematic, mainly because of cost, logistics, accessibility of health 
services and uncertainties about ZDV efficacy in women practising 
breastfeedmg. In order to reduce the burden of HIV infection in 
children world-wide. The utmost priority remains to prevent HIV 
heterosexual transmission in young women at the first place. 
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The Public Health Implications of HIV/AIDS 
Research in Africa 
K. De Cock. Department of Clinical Sciences, London School ofHygiene 
G- Tropical Medicine, London, UK 
Research in Afiica has contributed greatly to understandmg of the 
transmission, epidemiology and social impact of HiV/AIDS. Exam- 
ples of subjects profoundly duenced  by work on the &ican con- 
tinent include evaluation of serologic tests for HIV-1 and HIV-2 and 
their Merent subtypes, mother-to-child trammission of HIV/AIDS, 
and the interaction of HIV/AIDS and sexually transmitted diseases 
(STD). Based on research data, achievable biomedical and social in- 
terventions can be reliably proposed, including strengthened surveil- 
lance, education of youth about s e x u a l  health, strengthening of STD 
control programmes (incorporating education for behaviour change 
and condom promotion), securing the supply and uriluation of 
blood, strengthening tuberculosis control, assurance of a minimum 
standard of care for HIV/AIDS, and promoting the education and 
rights of women. Other practical benefits fium research have been 
the training and development of a cadre of indgenous researchers 
and health professionah whose influence extends beyond their own 
societies. The results of research in Mica have great implications for 
HIV/AIDS prevention efforts elsewhere including in Asia and the 
industrialized world. 
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burgdohrisensu lato in its wild state 
L. Gern. Instifut de Zoologie, Neuchrltel, Switzerland 
Lyme borreliosis (LB) is the most prevalent tick-borne disease in 
temperate areas of the Northern hemisphere. In Europe, the distri- 
bution of LB is correlated with the distribution of the tick Lvodes 
ricinus. In developing clinical madestations, humans reveal the pres- 
ence of natural foci in which B. burgdolferi (BB) circulates in cycles 
between ticks and vertebrate hosts. LB exists as a zoonosis, that 
means that the maintenance of Bb in nature is independent of hu- 
European LB can be caused by three different genomic species: Bb 
sensu stricto, B. garinii and B. afzelii. Characterization of spirochaetal 
isolates obtained fium I .  ricinus suggests that Bb s l  contains more than 
three species. The division in genomic groups seems to have cltnical 
relevance for LB in Europe. Borreliae which infect humans have 
their origin in the reservoir hosts such as rodents, birds, squirrel, 
hares and hedgehogs. These animal species are known to harbour 
Bb sl and to transmit Bb to I .  ricinus ticks. Recent studies indcate 
that an association exists between rodents and B. dzelii, and between 
birds and B .  garinii and spirochaetes of group VS116. 
In Europe, in addition to I .  ricinus, 15 other tick and insect species 
have been found lnfected by Bb but the role of most of them as 
vectors of Bb remains unclear. However, I. hexagonus and I .  uriae are 
able to maintain enzootic transmission cycles involving hedgehogs 
and seabirds, respectively. The potential public health significance of 
Bb in these tick species, in areas where I. ricinus whch transmits Bb 
to humans is absent, remains unclear. 
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Repartition 
G. Baranton. F 
No abstract available. 
Serological aspects and diagnosis of Lyme 
borreliosis in Europe 
E.C. Guy. Public Health Laboratory, Swansea SAZ 8QA, UK 
The serological diagnosis of Lyme &ease is &cult due both to 
the low level of specific antibody typically present in early infec- 
tion and the relatively high levels of potentially cross-reacting anti- 
body prevalent in the healthy population. In Europe, where Merent 
genomospecies of Boneliu burgdorferi s.1. are found, choice of anti- 
genic strain(s) in serological tests must also be considered. Further, 
there is presently no consensus as to the most appropriate test or 
combination of tests and, in addition, the potential of immunoblot 
as a confirmatory test is unclear. 
European multi-centre studies have been undertaken recently 
aimed both at comparing present laboratory strategies for serologi- 
cal testing, assessing overall diagnostic performance, and promoting 
standardisation. These include establishing agreed criteria for im- 
munoblot positivity, and a quality assurance scheme involving 36 
laboratories fmm 23 European states. In the latter study, in addition 
to returning their results, laboratories also provided information on 
types and combinations of serological tests employed. 51% of lab- 
oratories identified all 8 samples correctly. A combination of EL4 
and immunoblot was the most commonly used strategy. In a study 
of 54 erythema migram sera submitted h m  different geographical 
locations within Europe and tested by 5 labs in Werent countries 
there was no clear correlation for seropositive results between the 
country of origin of sera and country of the laboratory. Also, inclu- 
sion of multiple B. dorferi genomospecies did not appear to improve 
sensitivity of overall testing. 
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Approaches to Control by Vaccination Against 
European Lyme Disease: Concepts and Issues 
Y. Lobet. B 
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Selective targets for antiinfectives against 
bacteria 
(Joint Symposium with the ICAAC Program 
Com mittee) 
Recent Insights in the Metabolism of the 
Bacterial Cell Wall: Novel Targets for Antibacterial 
Agents 
J.-V Holtje. Max-Planck-Instirut J%r Enrwicklungsbiologie, Tiibingen, 
Germany 
The bacterial cell wall is fortified by the biopolymer murein (pep- 
tidoglycan), a meshwork of glycan strands that are cross-linked by 
peptide bridges. The murein layer forms a covalently closed string- 
bag-like structure, called sacculus. Thus, p w t h  of a bacterium de- 
pends on the simultaneous enlargement of its murein sacculus. In or- 
der to enlarge the murein netting the concerted activities of enzymes 
cleaving meshes and e n m e s  inserting new subunits, that is murein 
hydrolases and synthases, are needed. Most important however, the 
murein hydrolases must not act separately to avoid dissolution of 
the stress-bearing sacculus and hence bacteriolysis. Recent experi- 
mental results indicate that one way of controlling the potentially 
autolytic murein hydrolases seems to be their integration within a 
multienzyme complex, a murein synthesizing machmery combining 
both hydrolases and syntheses. Accordingly, any block in the sup- 
ply of activated murein precursors will result in an idling of the 
machinery with the murein hydrolases degradmg the murein. Bac- 
teriolysis is indeed the hallmark of most murein synthesis inhibitors. 
The conception of a murein synthesizing machinery suggests a novel 
target for antibiotics. Compounds interfering with the assembly of a 
functional machinery are expected to block further enlargement of 
the sacculus and moreover are likely to induce autolysis due to the 
missing control of the hydrolases by the complex. 
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Discovery 
Is22] Topoisomerases as Targets for 4-Quinolones 
D.C. Hooper, D.M. Breines, B. Fournier. Infecfiotu Disease Unit, 
Massachusetts General Hospital, H a m r d  Medical School, Boston, MA, 
USA 
DNA gyrase w&originally identified as a target of 4-quinolones 
&om resistance mutations in W A  and later gyB,  the genes encoding 
the two enzyme subunits, GyrA and GyrB, in Escheriskia coli. The 
clustering of resistance mutations within domains of GyrA and GyrB 
and the reduction in binding of quinolones to resistant gyrase-DNA 
complexes indicated that resistance was mediated by enzyme changes 
that reduced drug binding af2inity Recent models based on the crys- 
tal structure of the yeast topoisomerase I1 homolog localize altered 
amino acids of mutant GyrA near the site of DNA strand breakage 
and suggest a means for drug binding to antagonize enzyme func- 
tion and trap DNA deavage intermediates. Altered amino acids of 
mutant GyrB, however, are distantly placed from those in GyrA and 
from the jaws of the proposed clamps involved in DNA strand pas- 
sage, leaving unclear how these changes might effect resistance. More 
recently topoisomerase IV, a homolog of DNA gyrase encoded by 
the parC and parE genes, has been identified as a quinolone target. 
Resistance mutations in parC and parE in regions sunilar to those 
of gyrA and ~ y r B  have been found. parC and parE mutations in E.  
coli, however, cause resistance to ciprofloxacin only in the presence 
of resistant gyrase, indcating that topoisomerase IV is a secondary 
target of ciprofloxacin. In S. auras and Streptococcus pneumoniae, in 
contrast, parC mutations alone are sufficient to cause low-level resis- 
tance, and gyrA mutations cause ciprofloxacin resistance only in the 
presence of resistant topoisomerase rV, indicating that topoisomerase 
IV is the principal target. In recent work by others the sensitivity 
of the enzymes purified from E .  coli and S. aureus indmted that 
species-specific Merences in the primary targets of ciprofloxacin are 
likely determined by the enzyme with the most drug sensitivity. 
Genetic Control of Methicillin Resistance in 
Staphylococci: Possibilii for New Antimicrobial 
Targets 
B. Berger-Bachi. Institute of Medical Microbiology, University of Ziin'rh, 
Switzerland 
Methidm resistance in Staphyloroccus aureus is due to the acquisition 
of an additional, low &ty penidin-bindmg protein, PBPZ', that 
adds to the resident four PBPs of the cells. This foreign PBPZ' needs 
specific conditions for optimal expression of methicillin resistance. . 
Any changes in the balance or chemistry of peptidoglycan precursor 
formation has usually negative effects on the ability of PBPZ' to 
confer methidm resistance. The most important role plays thereby 
the characteristic pentaglycine side-chain (Glyl-5) that is attached to 
the peptidoglycan stem-peptide. It functions as acceptor in the PBP 
catalysed transpeptidase reaction. Its length and flexibihty allows a 
high cross-linking between the peptidoglycan strands that form the 
murein sacculus. Shortening of rhis side-chain abolishes methicillin 
resistance. The proteins involved in the addition of Gly2-Gly3 and 
of Gly4-Gly5 have been identified as F e d  and F e d ,  respectively. 
They are encoded by the f d B  operon. Although f e d B  Null 
mutants are still viable under laboratory conditions, their growth is 
strongly impaired. They are hypersusceptible to a l l  &lactams as well 
as to aIl other classes of antibiotics. F e d  and FemB are therefore 
potential targets for new antibacterial agents that may restore the 
efficacy of b-lactams against methicillin resistant S. aurm.  A fuaher 
promising drug-target is the not yet identified F e d ,  postulated to 
catalyse the attachment of the first glycine residue of the side-chain 
to the stem-peptide. 
New automated methods for identification 
and antimicrobial susceptibility testing 
Rapid Identification of Clinically Relevant 
Gram-Negative Rods 
J. Bille. University Hospital, Lausanne, Switzerland 
Rapid identification of pathogenic bacteria is important chcally 
because it can offer clues toward antibiotic resistance, the route of 
mfection, and have an impact on patient care. 
From more than 130 species of Enterobacteriaceae known today, 
